Study results released this week at the annual EuroPCR conference in Paris indicated that half of transcatheter aortic valve replacements had signs of degeneration within 10 years. The study looked at 704 patients who had a TAVR procedure between April 2002 and May 2011, following 378 of them for up to 10 years. In the 100 patients who […]
EuroPCR 2016
EuroPCR 2016 Update: TAVR innovations, FFR systems in the spotlight
UPDATED May 20, 2016, with more results out of Paris. St. Jude Medical (NYSE:STJ) announced it won CE Mark approval in the European Union for its PressureWire X Guidewire fractional flow reserve measurement system and is launching the product in Europe. The company announced the launch and clearance at the EuroPCR meeting in Paris this week. […]